Not Yet Recruiting
Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC
NCT07400094
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +15 more
- Locations
-
- P.A. Hertsen Moscow Oncology Research Institute Moscow, Russia